Publications by authors named "Maria V Prates"

Claim this Profile
A
A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study.
Rebeca Rodríguez-Veiga, Cristina Gil, Marta Sobas, Laura Torres-Miñana, Carmen Botella, Maria Virginia Prates

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project.
Andrei Shustov, Maria Elena Cabrera, Monica Civallero, Monica Bellei, Young Hyeh Ko, Maria Virginia Prates

Blood Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplantation improves survival in relapsed Hodgkin lymphoma patients achieving complete remission after salvage treatment.
María Marta Rivas, Mariano Berro, María Virginia Prates, Sebastián Yantorno, Lorena Fiad

Bone Marrow Transplant· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO).
Ana L Basquiera, María M Rivas, Guillermina Remaggi, Graciela Klein, Vera Milovic, María V Prates

Hematology· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: a multicenter experience from Argentina.
Ana L Basquiera, Silvia Pizzi, Agustín González Correas, Pablo G Longo, Wanda C Goldman, María V Prates

Pediatr Blood Cancer· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partial and total monosomal karyotypes in myelodysplastic syndromes: comparative prognostic relevance among 421 patients.
Carolina B Belli, Raquel Bengió, Pedro Negri Aranguren, Francisco Sakamoto, María G Flores, María V Prates

Am J Hematol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.
Santiago Pavlovsky, Claudia Corrado, Miguel A Pavlovsky, María V Prates, Lucía Zoppegno

Clin Lymphoma Myeloma Leuk· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis